We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
GH Secretion in Prader-Labhard-Willi Syndrome: Somatotrope Responsiveness to GHRH is Enhanced by Arginine but not by Pyridostigmine.
- Authors
Beccaria, L.; Bosio, L.; Sanzari, A.; Aimaretti, G.; Ghigo, E.; Chiumello, G.
- Abstract
Low somatotrope responsiveness to secretagogues has been reported in patients affected by Prader-Labhard-Willi Syndrome (PLWS). In normal subjects, GH response to GHRH is known to be greatly potentiated to the same extent by pyridostigmine (PD) or arginine (ARG) which probably act via inhibition of hypothalamic somatostatin release. To clarify somatotrope responsiveness in 7 PLWS patients, we studied GH response to GHRH alone and to GHRH combined with PD or ARG. Eight normal short children were studied as controls (NC). GH response to GHRH in PLWS was lower than in NC (AUC: 615 ± 205 μg/l·h, vs 1271 ± 333 μg/l·h, p < 0.02). In NC, the GHRHinduced GH rise was potentiated to the same extent by PD or ARG. In contrast, in PLWS PD failed to increase the GH response to GHRH (AUC: 615 ± 205 μg/l·h vs 621 ± 176 μg/l·h, n.s.) which was enhanced by ARG (AUC: 615 ± 205 μg/l·h vs 1633 ± 425 μg/l-h, p < 0.02). However, the GH response to GHRH + ARG in PLWS was lower than in NC. In conclusion, our results demonstrate that in PLWS the low somatotrope responsiveness to GHRH is not enhanced by cholinergic potentiation while it is increased by arginine.
- Publication
Journal of Pediatric Endocrinology & Metabolism, 1996, Vol 9, Issue 6, p577
- ISSN
0334-018X
- Publication type
Article
- DOI
10.1515/jpem.1996.9.6.577